Represented Biocept, Inc. (Nasdaq:BIOC) in its $19 million initial public offering. The San Diego-based oncology diagnostics company offered 1.9 million shares of common stock for $10 each. Read the press release.
Represented Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) in its acquisitions of Neurogen Corporation (Nasdaq: NRGN), CyDex Pharmaceuticals, Inc., and Metabasis Therapeutics, Inc. (Nasdaq: MBRX).
Represented Synbiotics Corporation (SYNB) in its $20 million acquisition by Pfizer Animal Health, part of Pfizer Inc. (NYSE: PFE).
Harvard Law School, J.D., 1979, magna cum laude
Yale University, B.A., 1975, magna cum laude
Memberships & Associations
- Past President, San Diego County Bar Association
- Phi Beta Kappa